儿童CKD进展与肾小管健康、损伤及炎症尿液生物标志物相关
在CKD儿童队列中,中位随访6.5年,38%患儿达到CKD进展复合终点。尿EGF最低四分位者进展风险为最高四分位的7.1倍(95%CI 3.9-20.0);尿KIM-1、MCP-1、α-1微球蛋白最高四分位者风险也显著升高。将五种标志物加入临床模型可提高对CKD进展的区分和重分类能力。
要点
- 儿童CKD患者中,尿EGF降低与CKD进展风险独立相关,最低四分位风险为最高四分位的7.1倍。
- 尿KIM-1、MCP-1、α-1微球蛋白升高也与CKD进展风险显著相关。
- 五种尿液标志物联合加入临床模型可改善对CKD进展的预测区分度与重分类。
核心结论
- 多变量调整后,尿EGF降低及尿KIM-1、MCP-1、α-1微球蛋白升高分别与儿童CKD进展相关。
研究设计与样本
- 前瞻性CKD in Children Study纳入6月龄至16岁、eGFR 30-90ml/min per 1.73m2的儿童,共665例,中位随访6.5年。
主要发现
- 665例中252例(38%)达到CKD进展复合终点(eGFR下降50%或肾衰竭)。
- 尿EGF最低四分位者CKD进展风险为最高四分位的7.1倍(aHR 7.1;95%CI 3.9-20.0)。
- 尿KIM-1、MCP-1、α-1微球蛋白最高四分位者CKD进展风险显著高于最低四分位者。
- 将五种生物标志物加入临床模型可提高对CKD进展的区分度和重分类能力。
关键数值与推荐
- 尿液生物标志物于入组后中位5个月(IQR 4-7)检测,并以尿肌酐校正(标志物浓度除以尿肌酐浓度)。
- 主要结局为随访期间CKD进展复合终点:eGFR下降50%或肾衰竭。
临床怎么用
- 在儿童CKD风险评估中,可考虑检测尿EGF、KIM-1、MCP-1、α-1微球蛋白等标志物以辅助识别进展高危患儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Novel urine biomarkers may improve identification of children at greater risk of rapid kidney function decline, and elucidate the pathophysiology of CKD progression. METHODS: We investigated the relationship between urine biomarkers of kidney tubular health (EGF and α-1 microglobulin), tubular injury (kidney injury molecule-1; KIM-1), and inflammation (monocyte chemoattractant protein-1 [MCP-1] and YKL-40) and CKD progression. The prospective CKD in Children Study enrolled children aged 6 months to 16 years with an eGFR of 30-90ml/min per 1.73m2. Urine biomarkers were assayed a median of 5 months [IQR: 4-7] after study enrollment. We indexed the biomarker to urine creatinine by dividing the urine biomarker concentration by the urine creatinine concentration to account for the concentration of the urine. The primary outcome was CKD progression (a composite of a 50% decline in eGFR or kidney failure) during the follow-up period. RESULTS: Overall, 252 of 665 children (38%) reached the composite outcome over a median follow-up of 6.5 years. After adjustment for covariates, children with urine EGF concentrations in the lowest quartile were at a seven-fold higher risk of CKD progression versus those with concentrations in the highest quartile (fully adjusted hazard ratio [aHR], 7.1; 95% confidence interval [95% CI], 3.9 to 20.0). Children with urine KIM-1, MCP-1, and α-1 microglobulin concentrations in the highest quartile were also at significantly higher risk of CKD progression versus those with biomarker concentrations in the lowest quartile. Addition of the five biomarkers to a clinical model increased the discrimination and reclassification for CKD progression. CONCLUSIONS: After multivariable adjustment, a lower urine EGF concentration and higher urine KIM-1, MCP-1, and α-1 microglobulin concentrations were each associated with CKD progression in children.
引用
- Greenberg JH, Abraham AG, Xu Y, et al. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children. J Am Soc Nephrol. 2021. PMID: 34544821. doi:10.1681/ASN.2021010094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。